Zobrazeno 1 - 6
of 6
pro vyhledávání: '"German Baikalov"'
Autor:
L. A. Oleinik, V. A. Svyatchenko, Pavel Madonov, A. A. Kotlyarova, German Baikalov, S. S. Legostaev, N. A. Kikhtenko
Publikováno v:
Bulletin of Experimental Biology and Medicine
The antiviral activity of recombinant human IFN-lambda type 1 (IFNλ-1) against culture strain of SARS-CoV-2 virus was determined by infecting a highly sensitive VeroE6 coronavirus cell culture after preincubation test (the cell monolayer was incubat
Autor:
V. A. Svyatchenko, Pavel Madonov, A. A. Kotlyarova, L. A. Oleinik, V. V. Udut, German Baikalov, S. S. Legostaev, N. A. Kikhtenko
Publikováno v:
Экспериментальная и клиническая фармакология. 84:15-20
Несмотря на значительные достижения в создании лекарственных средств, на сегодняшний день не существует эффективных универсальных пре
Publikováno v:
2022 Ural-Siberian Conference on Computational Technologies in Cognitive Science, Genomics and Biomedicine (CSGB).
Autor:
Marina Soldatova, Kseniya Bakhareva, Pavel Madonov, Konstantin Ershov, German Baikalov, Roman Knyazev
Publikováno v:
2021 IEEE Ural-Siberian Conference on Computational Technologies in Cognitive Science, Genomics and Biomedicine (CSGB).
In Russia, the drug Trombovazim, which has a direct thrombolytic effect, is registered and used in clinical practice. Indications for use in cardiology are acute myocardial infarction with ST elevation, in phlebology - chronic venous diseases. The ac
Publikováno v:
2020 Cognitive Sciences, Genomics and Bioinformatics (CSGB).
The immobilized subtilisins are bacterial proteinases with a high thrombolytic activity, capable of improving peripheral blood circulation by dissolving the blood clot and reducing manifestations of endothelial dysfunction. This article presents the
Autor:
Konstantin Ershov, Nataliya Mazarchuk, Nikolai Kikhtenko, K.V. Bakhareva, Pavel Madonov, German Baikalov, Larisa Olejnik
Publikováno v:
2019 International Multi-Conference on Engineering, Computer and Information Sciences (SIBIRCON).
Drugs based on interferon $\boldsymbol{\alpha}-2\mathbf{b}$ are highly effective in parenteral administration. When administered per os, their effectiveness is significantly less. Electron-beam immobilization of interferons $\boldsymbol{\alpha}-2\mat